Evidence map›Paper›PMID 29106364›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2017

The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Jennifer Jones, Jaimin Bhatt, Jonathan Avery, Andreas Laupacis, Katherine Cowan, Naveen Basappa, Joan Basiuk, Christina Canil, Sohaib Al-Asaaed, Daniel Heng and 4 more

Abstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Priorities of patients, caregivers and health-care professionals for health research - A systematic review.Health expectations : an international journal of public participation in health care and health policy · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  14. Review
  15. Engaging veteran stakeholders to identify patient-centred research priorities for optimizing implementation of lung cancer screening.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  16. Article
  17. Non-prostate Genitourinary Cancers, Tuesday, June 29, 2021.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
  18. Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population-based survey.Health expectations : an international journal of public participation in health care and health policy · 2021
    Article
  19. Article
  20. Shared decision-making for the management of small renal masses: Development and acceptability testing of a novel patient decision aid.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jennifer JonesCancer Rehabilitation and Survivorship Program, Princess Margaret Cancer Centre, University Health Network, and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Jaimin BhattDepartments of Surgery and Surgical Oncology (Division of Urology), Princess Margaret Cancer Centre, University Health Network, and the University of Toronto, Toronto, ON, Canada.
Jonathan AverySchool of Rehabilitation Sciences, University of Ottawa, ON, Canada.
Andreas LaupacisLi Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada.
Katherine CowanJames Lind Alliance, Southampton, United Kingdom.
Naveen BasappaDepartment of Oncology, University of Alberta, Edmonton, AB, Canada.
Joan BasiukKidney Cancer Research Network of Canada, University of Ottawa, Ottawa, ON, Canada.
Christina CanilDepartment of Internal Medicine, Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.
Sohaib Al-AsaaedDepartment of Medical Oncology, Dr. H. Bliss Murphy Cancer Centre, Memorial University of Newfoundland, St. John's, NF, Canada.
Daniel HengDepartment of Medical Oncology, University of Calgary and Tom Baker Cancer Centre, Calgary AB, Canada.
Lori WoodDivision of Medical Oncology, Department of Urology, Dalhousie University, Halifax, NS, Canada.
Dawn StaceyFaculty of Health Sciences, School of Nursing and Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Christian KollmannsbergerMedical Oncology, University of British Columbia and Medical Oncology BC Cancer Agency, Vancouver, BC, Canada.
Michael A S JewettDepartments of Surgery and Surgical Oncology (Division of Urology), Princess Margaret Cancer Centre, University Health Network, and the University of Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is critically important to define disease-specific research priorities to better allocate limited resources. There is growing recognition of the value of involving patients and caregivers, as well as expert clinicians in this process. To our knowledge, this has not been done this way for kidney cancer. Using the transparent and inclusive process established by the James Lind Alliance, the Kidney Cancer Research Network of Canada (KCRNC) sponsored a collaborative consensus-based priority-setting partnership (PSP) to identify research priorities in the management of kidney cancer. The final result was identification of 10 research priorities for kidney cancer, which are discussed in the context of current initiatives and gaps in knowledge. This process provided a systematic and effective way to collaboratively establish research priorities with patients, caregivers, and clinicians, and provides a valuable resource for researchers and funding agencies.

Identifiers

PMID29106364
PMCPMC5962944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.